Back to Top

NPJ Precision Oncology (NPJ PO)

Publisher :

Springer Nature Limited

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • precision oncology
  • Immunotherapies
  • Drug resistance
  • +4

e-ISSN :

2397-768X

Issue Frequency :

Monthly

Impact Factor :

6.8

Est. Year :

2017

Mobile :

442078334000

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

npjprecisiononcology@nature.com

Journal Descriptions

npj Precision Oncology considers research covering all aspects of basic science, translational, and clinical research in the field of precision oncology. The journal broadly defines precision oncology as cancer diagnosis, prognosis, prevention, and treatment tailored specifically to the individual patient based on the genetic and/or molecular profile of the patient. We welcome innovative, well-conducted, and deep studies. The journal covers a broad range of topics including but not limited to: Targeted therapy and precision medicine clinical trials and therapeutic strategies Biomarker studies that include both biological and external validation using an independent cohort Immunotherapies, immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, and immunomodulatory agents for personalized cancer treatment Applications of liquid biopsy techniques, including circulating tumor DNA, circulating tumor cells, and exosomes, for non-invasive cancer detection, monitoring, and treatment response assessment Tumor heterogeneity, clonal evolution, and tumor microenvironment dynamics in cancer progression, metastasis, and therapy resistance Genomic profiling and molecular characterization of cancer Drug resistance mechanisms and therapeutic strategies Clinical applications of predictive modeling, artificial intelligence, and computational oncology, including studies on large language models for research applications or clinical applications in oncology; and studies on deep learning-based data analysis in oncology with external validation and clear clinical potential Pharmacogenomics and drug metabolism, including secondary analyses of clinical trial datasets Microbiome studies only with clear evidence of relevance to a precision oncology treatment The journal offers more choice to Nature Portfolio authors who are seeking a fully open-access and more inclusive platform for publishing their work. The journal is led by oncology experts who collaborate to cultivate high-quality research. As part of the npj Series, this journal focuses on fostering global partnerships with the research community and other Springer Nature journals.


NPJ Precision Oncology (NPJ PO) is :

International, Peer-Reviewed, Open Access, Refereed, precision oncology, Immunotherapies, Drug resistance, Pharmacogenomics, drug metabolism, precision oncology treatment, ONCOLOGY , Online Monthly Journal

UGC Approved, ISSN Approved: P-ISSN , E-ISSN - 2397-768X, Established in - 2017, Impact Factor - 6.8

Provide Crossref DOI

Indexed in Scopus, WoS, DOAJ, PubMed

Not indexed in UGC CARE

Publications of NPJ PO

  • dott image June, 2022

Cell graph neural networks enable the precise prediction of patient survival in gastric cancer

Gastric cancer is one of the deadliest cancers worldwide. An accurate prognosis is essential for effective clinical assessment and treatment. Spatial patterns in the tumor microenvironment (...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile